Switch to:
More From Other Websites
Compelling Financial Benefit in Valeant's Latest Buy Feb 27 2015
Basics of the Salix–Valeant merger transaction Feb 26 2015
JANA sells stake in Equinix Feb 26 2015
The Salix–Valeant merger will follow a cash tender timeline Feb 26 2015
Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point Feb 26 2015
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report Feb 25 2015
Pharmacyclics considers $19bn sale Feb 25 2015
Biotech Pharmacyclics Spikes On Buyout Rumors Feb 25 2015
Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target Feb 25 2015
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash Feb 25 2015
8:04 am Valeant Pharma: PROVENGE demonstrates sustained immune response two years after treatment in... Feb 25 2015
Top Growth Funds: Large Caps Making Inroads Feb 25 2015
PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in... Feb 25 2015
PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in... Feb 25 2015
Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity Feb 24 2015
Lannett Joins Big-Game Hunt For Drugmaker Acquisitions Feb 24 2015
Firms Bullish On Valeant Following Earnings, Acquisition Feb 24 2015
Valeant Pharmaceuticals (VRX) Stock Higher Today as Analyst Increases Price Target on Salix Deal Feb 24 2015
Jim Cramer on Valeant: This Is an Amazing Pharmaceutical Firm Feb 24 2015
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial... Feb 24 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK